![]() When discontinuing therapy, dosage should be reduced gradually by no more Successful response and in these cases periodic reassessment and consideration of dosage adjustment is required.ĭosage should be individualized for maximum beneficial effect with a lowest possible dose. Occasional patients with panic disorder may need as much as 10 mg a day to achieve a The maximum dose should notĮxceed 4 mg/day. Depending on the response, dose mayīe increased at intervals of 3 to 4 days in increments of no more than 1 mg per day. Treatment should be initiated with a dose of 0.25 to 0.5 mg three times daily. The metabolism of alprazolam is mediated largely through the action of CYP3As and so alprazolam is contraindicated with CYP3A inhibitors such as ketoconazole and itraconazole. Azor (ANTI-ANXIETY) binding to BNZ-1 is thought to influence sedation and anti-anxiety, BNZ-2 may influence memory, coordination, muscle relaxation, and anticonvulsive activity, and GABA-A may calm patients by increasing the affinity of GABA-A receptors for GABA. The mechanism by which its cell receptor interactions translate to a clinical effect is not known.Īzor (ANTI-ANXIETY) exerts its effects through interaction with BNZ-1, BNZ-2, and GABA-A receptors. Like all benzodiazepines, it causes a dose related CNS depressant activity varying from mild impairment of task performance to hypnosis.Īzor (ANTI-ANXIETY) is indicated to treat anxiety and panic disorders. Azor (ANTI-ANXIETY) is presumed to produce its effects via interacting with the Gamma Aminobutyric Acid (GABA) - benzodiazepine receptor complex. It is an anxiolytic with hypnotic and anticonvulsive properties. Azor (ANTI-ANXIETY) is a triazolo analogue of the 1,4-benzodiazepine class of drugs.
0 Comments
Leave a Reply. |